Naltrexone study extends to Juneau

Posted: Sunday, December 15, 2002

JUNEAU (AP) -- Researchers studying a drug used to decrease alcohol cravings have expanded their work to include Juneau.

The study of the drug Naltrexone is a collaborative effort between the Southeast Alaska Regional Health Consortium and the School of Medicine at Yale University.

The study is funded through a five-year grant by the National Institute on Alcohol Abuse and Alcoholism and the Office of Minority Health Research.

The study began in Sitka in January and was expanded to Haines and Klukwan in April. It started including Juneau last month.

Researchers are recruiting American Indians and Alaska Natives between 18 and 65 years of age for the study.

Dr. Robert Robin of Yale is the onsite principal investigator. He says the researchers hope to enroll 180 people over the next three years.

Subscribe to Peninsula Clarion

Trending this week:


© 2018. All Rights Reserved. | Contact Us